SS-31 10mg: A Complete Guide to the Elamipretide Research Peptide

SS-31 10mg vials hold 10 milligrams of the research peptide elamipretide. Learn reconstitution math, storage, side effects, and legal status for lab use.

ARTICLE OVERVIEW

SS-31 10mg vials hold 10 milligrams of the research peptide elamipretide. Learn reconstitution math, storage, side effects, and legal status for lab use.

SS-31 10mg refers to a single vial containing 10 milligrams of the research peptide SS-31, also known as elamipretide. It is sold as a lyophilized powder for laboratory research and is not an FDA-approved medication for human use. The 10mg format is one of the most common vial sizes because it offers enough material for multiple experiments without requiring a large upfront purchase.

What Is SS-31 (Elamipretide)?

SS-31 is a synthetic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2. It is designed to concentrate in the inner mitochondrial membrane, where it binds to cardiolipin, a phospholipid closely tied to energy production.

Scientists study SS-31 for its effects on mitochondrial electron transport and reactive oxygen species. Typical laboratory research areas include:

  • Mitochondrial dysfunction models in cell culture
  • Cardiac ischemia-reperfusion experiments in animal models
  • Skeletal muscle aging and exercise-capacity research
  • Neurodegenerative and metabolic stress models

Elamipretide is the clinical name used in human trials. Those trials have explored Barth syndrome, primary mitochondrial myopathy, heart failure, and dry age-related macular degeneration, but results have been mixed and the compound has not received FDA approval for any indication.

A 10mg vial balances cost, stability, and convenience. Lyophilized peptide powder stays stable for long periods when frozen, and one vial can be split into several smaller aliquots after reconstitution.

Vial SizeTypical Research Use1 mg Aliquots Available
5 mgSmall pilot assays5
10 mgStandard bench workflow10
50 mgLong-term or multi-arm studies50

The 10mg size is a middle ground: large enough for a multi-week study, small enough that unused material does not sit in storage for years.

SS-31 10mg Reconstitution Math

Proper ss-31 10mg reconstitution starts with the concentration you need, not with a fixed volume of diluent. Adding more liquid produces a weaker solution; adding less produces a stronger one. The table below shows the most common laboratory dilutions for a 10mg vial.

Diluent AddedResulting ConcentrationVolume Equal to 1 mg
1 mL10 mg/mL0.1 mL
2 mL5 mg/mL0.2 mL
5 mL2 mg/mL0.5 mL
10 mL1 mg/mL1.0 mL

Use sterile water or bacteriostatic water, inject slowly down the inside wall of the vial, and swirl gently instead of shaking. Shaking can denature peptides and create foam that makes accurate withdrawal difficult.

Label the vial with the date and the final concentration. Most labs refrigerate reconstituted SS-31 and use it within a few weeks, although stability data vary by supplier and by storage conditions.

Benefits and Side Effects Reported in Research

An honest ss-31 peptide benefits and side effects overview has to separate laboratory findings from clinical trial results. Cell and animal studies frequently report improved mitochondrial efficiency, but human trials have not consistently delivered the clinical benefit that early animal data suggested.

Reported ss-31 peptide side effects in early human studies were mostly mild and included injection-site reactions, headache, and urticaria. Long-term safety data in humans remain limited, and no large trial has followed participants for years.

SS-31 is not approved by the FDA for human use in the United States, and no research peptide should be treated as a proven treatment for any condition.

Anyone considering use outside a research setting should speak with a healthcare professional first, particularly people taking prescription medications or managing a chronic condition.

SS-31 and MOTS-c: What the Stacking Discussion Looks Like

MOTS-c is a mitochondrial-derived peptide with a different mechanism of action, and researchers sometimes study the two compounds side by side. There is no published human trial of an ss-31 and mots-c protocol, so any claim about combining them is theoretical.

Because both peptides influence mitochondrial signaling, an additive or overlapping effect cannot be ruled out. People reading an ss-31 peptide review that promises dramatic results from stacking should look for citations from peer-reviewed sources rather than testimonials.

Storage, Purity, and Sourcing

  • Store lyophilized powder at -20°C, protected from light and moisture.
  • Refrigerate reconstituted solution and avoid repeated freeze-thaw cycles.
  • Request a third-party certificate of analysis showing HPLC purity and mass spectrometry confirmation.

Purity matters more than price. A vial labeled 10mg that contains degraded peptide, underfilled powder, or unidentified fillers is not a bargain for any laboratory. Buyers should verify that a vendor publishes lot-specific testing before ordering.

SS-31 is not FDA-approved for human use in the United States, and 10mg vials are typically labeled "for research use only." They are not intended for human or veterinary consumption.

Purchasing or possessing research peptides outside a legitimate research setting may violate state or local laws and institutional policies. This article is general information and is not medical advice.

Frequently Asked Questions

Is SS-31 approved for human use in the United States?

No. Elamipretide, the clinical name for SS-31, remains an investigational compound. The FDA has not approved it for any human indication, and 10mg vials are sold strictly for laboratory research use.

How much bacteriostatic water do I add to an SS-31 10mg vial?

The volume depends on the concentration you want. Adding 5 mL yields 2 mg/mL, while adding 10 mL yields 1 mg/mL, so each 1 mg aliquot measures 0.5 mL or 1.0 mL respectively. Inject the water slowly down the vial wall and swirl gently instead of shaking.

What side effects have been reported with SS-31?

In early human trials, reported side effects were generally mild and included injection-site reactions, headache, and urticaria. Long-term safety data in humans are limited, and anyone considering use should consult a healthcare professional.

Research information notice

This page provides educational research information and does not replace medical advice, diagnosis, or treatment.